Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis

Cancer Treatment Reviews

Volumn 41, Issue 10, 2015, Pages 971-978

  Nishijima, Tomohiro F ^a   Muss, Hyman B ^a   Shachar, Shlomit S ^a   Tamura, Kazuo ^b   Takamatsu, Yasushi ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b FUKUOKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Lymphocyte to monocyte ratio (LMR); Meta analysis; Prognostic factor; Solid tumors; Systematic review

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; DISEASE FREE SURVIVAL; HUMAN; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE TO MONOCYTE RATIO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; QUANTITATIVE ANALYSIS; SOLID TUMOR; SYSTEMATIC REVIEW; BLOOD; CYTOLOGY; DISEASE COURSE; LYMPHOCYTE; LYMPHOCYTE COUNT; META ANALYSIS; MONOCYTE; MORTALITY; NEOPLASM; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MONOCYTES; NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84958775961     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2015.10.003     Document Type: Review

References (53)

1. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998;339(21):1506-14 [Epub 1998/11/20].
2. Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 2009;69(13):5383-91 [Epub 2009/06/25].
3. Ceze N, Thibault G, Goujon G, Viguier J, Watier H, Dorval E, et al. Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy. Cancer Chemother Pharmacol 2011;68(5):1305-13 [Epub 2011/03/31].
4. Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers 2014;6(3):1670-90 [Epub 2014/08/16].
5. Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, et al. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer 2005;93(3):273-8 [Epub 2005/07/30].
6. Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, et al. Prognostic value of pretreatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol 2012;124(1):92-7 [Epub 2011/10/22].
7. Koh YW, Shin SJ, Park C, Yoon DH, Suh C, Huh J. Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumourassociated macrophages. Hematol Oncol 2014;32(4):178-86 [Epub 2014/06/ 10].
8. Lin B, Chen C, Qian Y, Feng J. Prognostic role of peripheral blood lymphocyte/monocyte ratio at diagnosis in diffuse large B-cell lymphoma: a meta-analysis. Leuk Lymphoma 2015:1-6 [Epub 2015/02/18].
9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62(10):1006-12 [Epub 2009/07/28].
10. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform metaanalyses of the published literature for survival endpoints. Stat Med 1998;17 (24):2815-34 [Epub 1999/01/28].
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60 [Epub 2003/09/06].
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177-88 [Epub 1986/09/01].
13. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088-101 [Epub 1994/12/01].
14. Egger M, Davey Smith G, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34 [Epub 1997/10/06].
15. Xiao WW, Zhang LN, You KY, Huang R, Yu X, Ding PR, et al. A low lymphocyteto- monocyte ratio predicts unfavorable prognosis in pathological T3N0 rectal cancer patients following total mesorectal excision. J Cancer 2015;6 (7):616-22 [Epub 2015/06/17].
16. Fujiwara Y, Misawa T, Shiba H, Shirai Y, Iwase R, Haruki K, et al. Postoperative peripheral absolute blood lymphocyte-to-monocyte ratio predicts therapeutic outcome after pancreatic resection in patients with pancreatic adenocarcinoma. Anticancer Res 2014;34(9):5163-8 [Epub 2014/09/10].
17. Rochet NM, Porrata LF, Kottschade LA, Grotz TE, Markovic S. Preoperative peripheral blood lymphocyte/monocyte ratio and survival in patients with resected stage IV melanoma. J Clin Oncol 2012;30(Suppl.):1 [abstr 8600].
18. Li J, Jiang R, Liu WS, Liu Q, Xu M, Feng QS, et al. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS ONE 2013;8(12): e83069 [Epub 2014/01/05].
19. Szkandera J, Gerger A, Liegl-Atzwanger B, Absenger G, Stotz M, Friesenbichler J, et al. The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer 2014;135(2):362-70 [Epub 2013/12/19].
20. Stotz M, Pichler M, Absenger G, Szkandera J, Arminger F, Schaberl-Moser R, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer 2014;110(2):435-40 [Epub 2013/12/21].
21. Lin GN, Peng JW, Xiao JJ, Liu DY, Xia ZJ. Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet. Med Oncol 2014;31(7):70 [Epub 2014/06/15].
22. Hutterer GC, Stoeckigt C, Stojakovic T, Jesche J, Eberhard K, Pummer K, et al. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma. Urol Oncol 2014;32(7):1041-8 [Epub 2014/07/17].
23. Lin GN, Peng JW, Liu DY, Xiao JJ, Chen YQ, Chen XQ. Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy. Tumour Biol 2014;35(11):10849-54 [Epub 2014/08/02].
24. Zhou X, Du Y, Xu J, Huang Z, Qiu T, Wang X, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer. Tumour Biol 2014;35(11):11659-66 [Epub 2014/08/21].
25. Temraz S, Mukherji D, Farhat ZA, Nasr R, Charafeddine M, Shahait M, et al. Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis. BMC Urol 2014;14:76 [Epub 2014/09/23].
26. Hu P, Shen H, Wang G, Zhang P, Liu Q, Du J. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study. PLoS ONE 2014;9(9):e108062 [Epub 2014/10/ 03].
27. Ni XJ, Zhang XL, Ou-Yang QW, Qian GW, Wang L, Chen S, et al. An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy. PLoS ONE 2014;9(11):e111886 [Epub 2014/11/06].
28. Stotz M, Szkandera J, Stojakovic T, Seidel J, Samonigg H, Kornprat P, et al. The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer. Clin Chem Lab Med 2015;53(3):499-506 [Epub 2014/11/13].
29. Go SI, Kim RB, Song HN, Kang MH, Lee US, Choi HJ, et al. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer. Med Oncol 2014;31(12):323 [Epub 2014/11/25].
30. Huang Y, Feng JF. Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2015;8:137-45 [Epub 2015/01/23].
31. Qi Q, Geng Y, Sun M, Wang P, Chen Z. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer. Pancreatology 2015;15(2):145-50 [Epub 2015/ 02/03].
32. Hutterer GC, Sobolev N, Ehrlich GC, Gutschi T, Stojakovic T, Mannweiler S, et al. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma. J Clin Pathol 2015;68 (5):351-5 [Epub 2015/02/11].
33. Kozak MM, von Eyben R, Pai JS, Anderson EM, Welton ML, Shelton AA, et al. The prognostic significance of pretreatment hematologic parameters in patients undergoing resection for colorectal cancer. Am J Clin Oncol 2015 [Epub 2015/03/11].
34. Neofytou K, Smyth EC, Giakoustidis A, Khan AZ, Williams R, Cunningham D, et al. The preoperative lymphocyte-to-monocyte ratio is prognostic of clinical outcomes for patients with liver-only colorectal metastases in the neoadjuvant setting. Ann Surg Oncol 2015 [Epub 2015/03/17].
35. Neal CP, Cairns V, Jones MJ, Masood MM, Nana GR, Mann CD, et al. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases. Med Oncol 2015;32(5):144 [Epub 2015/03/27].
36. Han LH, Jia YB, Song QX, Wang JB, Wang NN, Cheng YF. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma. Asian Pac J Cancer Prev 2015;16 (6):2245-50 [Epub 2015/04/01].
37. Deng Q, He B, Liu X, Yue J, Ying H, Pan Y, et al. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med 2015;13:66 [Epub 2015/04/ 18].
38. Wang L, Long W, Li PF, Lin YB, Liang Y. An elevated peripheral blood monocyteto- lymphocyte ratio predicts poor prognosis in patients with primary pulmonary lymphoepithelioma-like carcinoma. PLoS ONE 2015;10(5): e0126269 [Epub 2015/05/08].
39. Zhang GM, Zhu Y, Luo L, Wan FN, Zhu YP, Sun LJ, et al. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy. Tumour Biol 2015 [Epub 2015/06/03].
40. Jiang R, Cai XY, Yang ZH, Yan Y, Zou X, Guo L, et al. Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma. Chin J Cancer 2015;34(1):23 [Epub 2015/06/13].
41. Cummings M, Merone L, Keeble C, Burland L, Grzelinski M, Sutton K, et al. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival. Br J Cancer 2015;113(2):311-20 [Epub 2015/06/ 17].
42. Chen L, Zhang F, Sheng XG, Zhang SQ. Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgery. Onco Targets Ther 2015;8:1355-62 [Epub 2015/06/20].
43. Chang Y, An H, Xu L, Zhu Y, Yang Y, Lin Z, et al. Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma. Br J Cancer 2015;113(4):626-33 [Epub 2015/07/03].
44. Ozawa T, Ishihara S, Kawai K, Kazama S, Yamaguchi H, Sunami E, et al. Impact of a lymphocyte to monocyte ratio in stage IV colorectal cancer. J Surg Res 2015 [Epub 2015/07/15].
45. Yamagishi T, Fujimoto N, Nishi H, Miyamoto Y, Hara N, Asano M, et al. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma. Lung Cancer 2015 [Epub 2015/08/12].
46. Li ZM, Huang JJ, Xia Y, Sun J, Huang Y, Wang Y, et al. Blood lymphocyte-tomonocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. PLoS ONE 2012;7(7):e41658 [Epub 2012/08/23].
47. Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica 2012;97(2):262-9 [Epub 2011/ 10/14].
48. Man YG, Stojadinovic A, Mason J, Avital I, Bilchik A, Bruecher B, et al. Tumorinfiltrating immune cells promoting tumor invasion and metastasis: existing theories. J Cancer 2013;4(1):84-95 [Epub 2013/02/07].
49. Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011;29(15):1949-55 [Epub 2011/04/13].
50. Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 2011;105(1):93-103 [Epub 2011/06/02].
51. Fortes C, Mastroeni S, Mannooranparampil TJ, Passarelli F, Zappala A, Annessi G, et al. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival. Melanoma Res 2015;25(4):306-11 [Epub 2015/05/02].
52. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 2005;14(2):425-31 [Epub 2005/07/14].
53. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010;362(10):875-85 [Epub 2010/03/12].